Altamira Therapeutics Ltd.: xbrl:ActuarialAssumptionOfDiscountRates

Value{"value": 0.022}
Period (as of 2022-12-31)
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-23-040152
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/f2af267d-f15c-4a8d-8a6e-068ac335c04a

History